Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaques (Q64376800)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaques	article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaques (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

David C. Montefiori

12

object named as

David C Montefiori

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Marjorie Robert-Guroff

14

object named as

Marjorie Robert-Guroff

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

L Jean Patterson

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jennifer Beal

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Thorsten Demberg

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Ruth H Florese

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Nina Malkevich

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

David Venzon

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Kris Aldrich

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Ersell Richardson

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

V S Kalyanaraman

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Irene Kalisz

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Eun Mi Lee

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Frank A Robey

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

0 references

publication date

5 February 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

number of pages

16

1 reference

based on heuristic

inferred from page(s)

0 references

374

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

322-337

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

HIV vaccines: new frontiers in vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Induction of a virus-specific effector-memory CD4+ T cell response by attenuated SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

An adenovirus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Rapid and irreversible CD4+ T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV(DH12R) is systemic and synchronous

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Prevalence of antibodies to adenovirus serotypes 4 and 7 among unimmunized US Army trainees: results of a retrospective nationwide seroprevalence survey.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Development and homeostasis of T cell memory in rhesus macaque

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

A helical epitope in the C4 domain of HIV glycoprotein 120

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

A synthetic conformational epitope from the C4 domain of HIV Gp120 that binds CD4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

AIDS vaccine development and challenge viruses: getting real

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Control of simian immunodeficiency virus SIVmac239 is not predicted by inheritance of Mamu-B*17-containing haplotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

based on heuristic

inferred from DOI database lookup

A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.12.037

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2007.12.037

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18252262%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64376800&oldid=2076062491"